Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Mirtskhulava

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|March 16, 2019
Risk factors for unfavourable treatment outcomes among rifampicin-resistant tuberculosis patients in TajikistanM Makhmudova, Z Maxsumova, A Rajabzoda, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|December 25, 2008
Prevalence and risk factors for multidrug-resistant tuberculosis in the Republic of Georgia: a population-based studyN Lomtadze, R Aspindzelashvili, M Janjgava, et al.
IJTLD Open|July 11, 2024
Decentralised ECG monitoring for drug-resistant TB patients in ambulatory settingsM Mbenga, A Slyzkyi, V Mirtskhulava, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|April 19, 2008
Prevalence and risk factors for latent tuberculosis infection among health care workers in GeorgiaV Mirtskhulava, R Kempker, K L Shields, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|October 17, 2019
Rates and risk factors for nephrotoxicity and ototoxicity among tuberculosis patients in Tbilisi, GeorgiaM Buziashvili, V Mirtskhulava, M Kipiani, et al.
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases|August 23, 2024
Experiences in the introduction of bedaquiline pretomanid linezolid for drug-resistant tuberculosis in KyrgyzstanB Myrzaliev, M Ahmatov, A Duishekeeva, et al.
IJTLD Open|May 14, 2025
Treatment success rate and time to culture conversion under a prospective BPaL cohort studyE Burhan, J Sugiharto, M Soemarno, et al.
Plos One|November 19, 2024
Introducing BPaL: Experiences from countries supported under the LIFT-TB projectD F Wares, M Mbenga, V Mirtskhulava, et al.
IJTLD Open|April 17, 2026
High efficacy of BPaL among patients infected with <i>Mycobacterium tuberculosis</i> lineage 1 in the PhilippinesI Flores, M A A Tujan, R Basilio, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|March 16, 2019
Risk factors for unfavourable treatment outcomes among rifampicin-resistant tuberculosis patients in TajikistanM Makhmudova, Z Maxsumova, A Rajabzoda, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|December 25, 2008
Prevalence and risk factors for multidrug-resistant tuberculosis in the Republic of Georgia: a population-based studyN Lomtadze, R Aspindzelashvili, M Janjgava, et al.
IJTLD Open|July 11, 2024
Decentralised ECG monitoring for drug-resistant TB patients in ambulatory settingsM Mbenga, A Slyzkyi, V Mirtskhulava, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|April 19, 2008
Prevalence and risk factors for latent tuberculosis infection among health care workers in GeorgiaV Mirtskhulava, R Kempker, K L Shields, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|October 17, 2019
Rates and risk factors for nephrotoxicity and ototoxicity among tuberculosis patients in Tbilisi, GeorgiaM Buziashvili, V Mirtskhulava, M Kipiani, et al.
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases|August 23, 2024
Experiences in the introduction of bedaquiline pretomanid linezolid for drug-resistant tuberculosis in KyrgyzstanB Myrzaliev, M Ahmatov, A Duishekeeva, et al.
IJTLD Open|May 14, 2025
Treatment success rate and time to culture conversion under a prospective BPaL cohort studyE Burhan, J Sugiharto, M Soemarno, et al.
Plos One|November 19, 2024
Introducing BPaL: Experiences from countries supported under the LIFT-TB projectD F Wares, M Mbenga, V Mirtskhulava, et al.
IJTLD Open|April 17, 2026
High efficacy of BPaL among patients infected with <i>Mycobacterium tuberculosis</i> lineage 1 in the PhilippinesI Flores, M A A Tujan, R Basilio, et al.
Pageof 1